ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea
· Delayed Price · Currency is KRW 118,000
+100 (0.08%)
At close: Dec 5, 2025
ST Pharm Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 318,316 | 273,751 | 284,992 | 249,322 | 165,642 | 124,109 | Upgrade
|
| Other Revenue | - | -0 | - | -0 | -0 | - | Upgrade
|
| Revenue | 318,316 | 273,751 | 284,992 | 249,322 | 165,642 | 124,109 | Upgrade
|
| Revenue Growth (YoY) | 14.24% | -3.94% | 14.31% | 50.52% | 33.47% | 33.08% | Upgrade
|
| Cost of Revenue | 193,619 | 180,147 | 175,248 | 162,140 | 110,333 | 105,760 | Upgrade
|
| Gross Profit | 124,697 | 93,605 | 109,744 | 87,182 | 55,309 | 18,349 | Upgrade
|
| Selling, General & Admin | 45,156 | 40,069 | 41,120 | 37,665 | 28,034 | 19,496 | Upgrade
|
| Research & Development | 23,798 | 22,108 | 30,450 | 26,306 | 18,218 | 13,204 | Upgrade
|
| Amortization of Goodwill & Intangibles | 1,094 | 631.65 | 255.01 | 197.29 | 212.22 | 92.81 | Upgrade
|
| Other Operating Expenses | 194.36 | 464.7 | 1,069 | 863.35 | 761.82 | 1,820 | Upgrade
|
| Operating Expenses | 73,252 | 65,912 | 76,232 | 69,330 | 49,731 | 37,166 | Upgrade
|
| Operating Income | 51,445 | 27,693 | 33,512 | 17,851 | 5,578 | -18,817 | Upgrade
|
| Interest Expense | -7,738 | -7,738 | -6,106 | -2,868 | -5,157 | -644.58 | Upgrade
|
| Interest & Investment Income | 4,571 | 4,571 | 2,440 | 1,236 | 939.37 | 618.04 | Upgrade
|
| Earnings From Equity Investments | -246.09 | -246.09 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 13,298 | 13,298 | 1,809 | 3,607 | 3,361 | -1,922 | Upgrade
|
| Other Non Operating Income (Expenses) | -23,425 | -5,823 | -236.68 | 683.87 | 65.55 | 693.3 | Upgrade
|
| EBT Excluding Unusual Items | 37,905 | 31,755 | 31,418 | 20,511 | 4,786 | -20,072 | Upgrade
|
| Gain (Loss) on Sale of Investments | 12,390 | 12,390 | -8,063 | -628.83 | 147.24 | 3,258 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1,446 | -1,446 | -0.62 | -644.73 | -3,673 | -10.89 | Upgrade
|
| Asset Writedown | 47.79 | 47.79 | - | - | - | - | Upgrade
|
| Pretax Income | 48,897 | 42,747 | 23,354 | 19,237 | 1,260 | -16,825 | Upgrade
|
| Income Tax Expense | 12,917 | 10,283 | 5,831 | 1,721 | -2,117 | -3,670 | Upgrade
|
| Earnings From Continuing Operations | 35,979 | 32,464 | 17,523 | 17,516 | 3,377 | -13,155 | Upgrade
|
| Minority Interest in Earnings | 914.54 | 2,248 | 2,058 | 484.29 | -65.27 | 1,008 | Upgrade
|
| Net Income | 36,894 | 34,712 | 19,581 | 18,000 | 3,312 | -12,147 | Upgrade
|
| Net Income to Common | 36,894 | 34,712 | 19,581 | 18,000 | 3,312 | -12,147 | Upgrade
|
| Net Income Growth | 13.91% | 77.27% | 8.78% | 443.46% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 21 | 20 | 19 | 19 | 19 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 20 | 19 | 19 | 19 | 19 | Upgrade
|
| Shares Change (YoY) | 7.23% | 3.70% | - | 0.77% | 0.05% | - | Upgrade
|
| EPS (Basic) | 1795.21 | 1779.72 | 1041.07 | 957.00 | 177.50 | -651.11 | Upgrade
|
| EPS (Diluted) | 1795.21 | 1779.72 | 1041.00 | 957.00 | 177.00 | -651.11 | Upgrade
|
| EPS Growth | 6.23% | 70.96% | 8.78% | 440.68% | - | - | Upgrade
|
| Free Cash Flow | 15,003 | 26,646 | -41,946 | -53,448 | -44,522 | -37,924 | Upgrade
|
| Free Cash Flow Per Share | 730.04 | 1366.16 | -2230.12 | -2841.64 | -2385.36 | -2032.81 | Upgrade
|
| Dividend Per Share | 500.000 | 500.000 | - | - | - | - | Upgrade
|
| Gross Margin | 39.17% | 34.19% | 38.51% | 34.97% | 33.39% | 14.78% | Upgrade
|
| Operating Margin | 16.16% | 10.12% | 11.76% | 7.16% | 3.37% | -15.16% | Upgrade
|
| Profit Margin | 11.59% | 12.68% | 6.87% | 7.22% | 2.00% | -9.79% | Upgrade
|
| Free Cash Flow Margin | 4.71% | 9.73% | -14.72% | -21.44% | -26.88% | -30.56% | Upgrade
|
| EBITDA | 79,507 | 53,275 | 56,538 | 35,452 | 19,992 | -4,749 | Upgrade
|
| EBITDA Margin | 24.98% | 19.46% | 19.84% | 14.22% | 12.07% | -3.83% | Upgrade
|
| D&A For EBITDA | 28,062 | 25,582 | 23,027 | 17,600 | 14,414 | 14,068 | Upgrade
|
| EBIT | 51,445 | 27,693 | 33,512 | 17,851 | 5,578 | -18,817 | Upgrade
|
| EBIT Margin | 16.16% | 10.12% | 11.76% | 7.16% | 3.37% | -15.16% | Upgrade
|
| Effective Tax Rate | 26.42% | 24.05% | 24.97% | 8.95% | - | - | Upgrade
|
| Advertising Expenses | - | 1,221 | 705.83 | 324.5 | 83.11 | 141.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.